ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 872

Work Limitations and Disability in Patients with Systemic Vasculitis

Emma Ali Bateman1, Sherry Rohekar2, Christian Pagnoux3 and Lillian Barra1, 1Medicine, Division of Rheumatology, Western University, London, ON, Canada, 2Western University, London, ON, Canada, 3Mount Sinai Hospital, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: disability and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Despite recent advances in the treatment of systemic vasculitis (SV), direct consequences of the disease leading to impairments in physical and mental function can cause disability, which is an understudied aspect of SV.  The objective of this research was to assess work limitations and disability in patients with SV. 

Methods:

Patients aged >18 years old with SV (anti-neutrophilic cytoplasmic antibody-associated vasculitis (AAV), polyarteritis nodosa, large vessel vasculitis, IgA vasculitis, Behcet’s syndrome or cryoglobulinemic vasculitis) were recruited from a tertiary care Rheumatology clinic (London, Canada). Work disabled (WD) was defined as not working, early retirement, or reduced hours at work due to SV. Participants who were working at the time of enrolment completed the Work Limitations Questionnaire (WLQ). Other work-related measures were self-reported by questionnaire. At the time of enrolment, the Vasculitis Damage Index (VDI) was also obtained.

Results: 103 participants completed the study (mean age 58±17, 60% females, 48% with AAV, 26% LVV and 26% other). 52 (51%) subjects were WD or retired for reasons other than SV and were excluded from further analyses; 22 (21%) were WD secondary to SV and 29 (28%) did not report any disability. SV-related WD subjects were more likely to have a diagnosis of AAV and a lower level of education (p<0.01) than non-WD subjects. Mean VDI scores were higher in SV-related WD vs. non-WD subjects (1.9±2.7 vs. 2.9±1.4; p=0.015).  Involvement of musculoskeletal, peripheral vascular, ocular and neuropsychiatric systems was more common in WD. 38 subjects were working and completed the WLQ; their productivity loss was 8.9±7.2%, higher than control patients from the same center with Rheumatoid Arthritis and Ankylosing Spondylitis (4.5% and 5.8%, respectively). 

Conclusion: SV-related work disability occurred in 21% of patients and was associated with a diagnosis of AAV, lower levels of education, higher disease activity and damage scores.


Disclosure: E. A. Bateman, None; S. Rohekar, None; C. Pagnoux, None; L. Barra, None.

To cite this abstract in AMA style:

Bateman EA, Rohekar S, Pagnoux C, Barra L. Work Limitations and Disability in Patients with Systemic Vasculitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/work-limitations-and-disability-in-patients-with-systemic-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-limitations-and-disability-in-patients-with-systemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology